(1) Department of Thoracic Surgery, Mie University School of Medicine, 2-174 Edobashi, Tsu Mie, 514-8507, Japan
Abstract:
Background
Bronchorrhea is one of late complaints in patients with bronchioloalveolar carcinoma (BAC) and hampers their quality of life. Although an effective treatment for bronchorrhea in these patients has not been established, recently we have treated effectively one case of persistent bronchorrhea associated with clinical recurrent BAC with gefitinib (ZD1839, 'Iressa™'; AstraZeneca Japan; Osaka, Japan).
